Featured

24 January 2024

ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research

Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.

All
  • All
  • News
  • Articles
  • Events

Westminster Health Forum Keynote Seminar indicates the need for an integrated HealthScience approach to healthcare policy, decision-making and communications

Dr Richard White, Commercial Director, and Dr Polly Field, Value Demonstration Leader, attended the Westminster Health Forum Keynote Seminar on Next steps for NICE, priorities for the pharmaceutical industry, and Accelerated Access Review. This was held on Thursday 14 January 2016 and Richard contributed the following article to the transcript of proceedings. The agenda for…

Continue reading

Oxford PharmaGenesis joins top companies to launch new corporate responsibility initiative

As a leading healthcare communications company, Oxford PharmaGenesis takes its corporate social responsibilities very seriously. So when Tony Stratton, until recently High Sherriff of Oxfordshire, asked if we’d like to join other top Oxfordshire companies to take a stronger, more sustainable approach to working with local charities in the community, we signed up straight away….

Continue reading

Oxford PharmaTrotters run (more than) a marathon for Sport Relief

Yesterday, Oxford PharmaGenesis really went the extra mile to raise money for Sport Relief. Our keen trotters ran a total of 32.5 miles over courses in Tubney, Oxfordshire, Trafalgar Square, London, and Newtown, PA, USA, and raised more than £300.

Continue reading

Oxford PharmaGenesis highlights patient centricity in publication practice: report from TIPPA's 15th Annual Meeting

Multiple aspects of HealthScience – including rare diseases, real-world evidence, and health economics and outcomes research – were major topics for discussion at the 15th Annual Meeting of The International Publication Planning Association (TIPPA) last week, sponsored by Oxford PharmaGenesis. The meeting, held in San Diego on 29 February–1 March 2016, was attended by a…

Continue reading

Oxford PharmaGenesis research creates a buzz

Our research demonstrating the value of professional medical writing support has gained remarkable online attention since publication last week in BMJ Open. Based on a combination of online attention and sharing on social media, our article has achieved an Altmetric score of 52, putting it in the top 5% of all research outputs scored by…

Continue reading

SURE™ real-world data source assessments expand into new therapy areas

Oxford PharmaGenesis this week expanded its real-world evidence experience into the areas of respiratory and infectious diseases, with the commissioning of two new SURE™ (Systematic Understanding of Real-World Evidence) assessments. This brings to double digits the number of SURE™ projects initiated in the past 12 months, which have covered cardiology, neurology, diabetes, endocrinology, oncology, immunology…

Continue reading